8:00 am Check-In & Coffee

9:00 am Workshop A: Narrowing the Translatability Gap

Overcoming Species-Specific Limitations in Preclinical Models for Human Disease

• Paul Ashton President & Chief Executive Officer, Inflammasome Therapeutics

12:00 pm Lunch Break & Networking

1:00 pm Workshop B: Establishing the Correct Endpoints

Highlighting the Bottlenecks & Solutions for Inflammasome Target Indication Assessment

• Lauren Martens VP Biology, Neumora Therapeutics, Inc.

4:00 pm End of Pre-Conference Workshop Day